• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcarePharmaceuticalsImmuCell
    Picture of ImmuCell logo

    ICCC — ImmuCell News Story

    $10.250.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapHigh Flyer
    • Market Cap
      $93.09m
    • Enterprise Value
      $92.54m
    • Revenue
      $27.64m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ICCC Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ICCC Dividends
    All News

    NASDAQ RESUMED AT 11:10 AM

    Picture of ImmuCell logoImmuCell
    15/07/2020 16:10
    NASDAQ RESUMED  ICCC.O  AT 11:10 AM
    

    Recent news on ImmuCell

    See all news
    • Brief: Immucell Announces A 46% Increase In Product Sales In Quarter Three Of 2026, Based On Preliminary, Unaudited Sales Results

      12/10/2026 22:29
    • ImmuCell Q2 revenue rises on higher distributor volume, price realization

      13/08/2026 21:14
    • Brief: ImmuCell Corporation Q2 EPS USD 0.2

      13/08/2026 21:06
    • ImmuCell Q2 product sales rise 11.5% on strong US demand

      09/07/2026 21:19
    • ImmuCell Q1 sales, profit rise on seasonal demand; to moderate mid-year

      14/05/2026 21:19

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.